Posted in | News | Materials Science

Researchers Welcome New Solutions to Enhance the Integrity of Catalyst Characterization Studies

Micromeritics Instrument Corp., a leader in material characterization technology, is seeing enthusiastic interest from researchers keen to use the new Micromeritics in-situ Catalyst Characterization System (ICCS) to enhance the integrity of heterogeneous catalyst studies by adding new capabilities to existing reaction screening systems. Standard practice is to remove a catalyst from the reactor and transfer it to a separate system for characterization, following reaction, but this risks environmental contamination and compromising data quality. With the ICCS, a catalyst can be characterized at any point after a reaction, in the reactor, to gain representative data. The broad compatibility of the ICCS makes this extremely valuable insight into reaction, deactivation and regeneration widely accessible.

Micromeritics in situ Catalyst Characterization System (ICCS) connected to the Microactivity EFFI

Researchers use a wide range of different apparatus to assess catalyst performance. From in-house glassware units to sophisticated, automated systems such as our Micromeritics Microactivity Effi reactor. Following reaction, it is desirable to re-quantify defining characteristics such as the number of active catalysts sites, to observe any change. This typically means removing the catalyst from the reactor and transferring it to a chemisorption system. There is widespread recognition that this process undermines the integrity of the resulting characterization data, so we’re delighted to be able to offer a solution which so many people can use.

Dr Simon Yunes, Senior Scientist, Micromeritics

The ICCS can be connected to most existing, flowing test rigs, to deliver an extensive range of well-established catalyst characterization capabilities. The ability to simply add on this functionality enhances the value of existing equipment and makes the ICCS a valuable addition. The characterization techniques it enables include pulsed chemisorption and temperature programmed analyses (reduction, oxidation and desorption) which are applied to measure performance-defining metrics such as number of active sites, metal dispersion and activity under specific conditions. These analyses can be carried out at pressures up to 20 bar, depending on the rating of the attached apparatus, and the conditions of interest.

We’ve had excellent feedback from leaders in the field of catalyst development, who are already using the ICCS to access new information to drive their studies. A better understanding of the mechanisms of the reaction, catalyst deactivation, and regeneration are crucial for the commercialization of higher performance catalysts. The ICCS is a powerful solution for any researcher looking to efficiently augment and enhance their heterogeneous catalyst characterization strategies.

Dr Simon Yunes, Senior Scientist, Micromeritics

For more information on the Micromeritics In-situ Catalyst Characterization System please visit our product page here.  
 

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Micromeritics Instrument Corporation. (2020, January 08). Researchers Welcome New Solutions to Enhance the Integrity of Catalyst Characterization Studies. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=52808.

  • MLA

    Micromeritics Instrument Corporation. "Researchers Welcome New Solutions to Enhance the Integrity of Catalyst Characterization Studies". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=52808>.

  • Chicago

    Micromeritics Instrument Corporation. "Researchers Welcome New Solutions to Enhance the Integrity of Catalyst Characterization Studies". AZoM. https://www.azom.com/news.aspx?newsID=52808. (accessed November 21, 2024).

  • Harvard

    Micromeritics Instrument Corporation. 2020. Researchers Welcome New Solutions to Enhance the Integrity of Catalyst Characterization Studies. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=52808.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.